Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
HPV Test for Older Women Supported as Catch Up
For women over the age of 65 who have never had a high-risk HPV test, a “catch up” test may improve cervical cancer prevention.
Cervical (HPV)
Latest
Why the Triage Approach Will Improve Cervical Cancer Screening and Diagnosis
The triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Half of Eligible Women Prefer Self-Sampling for Cervical Screening
A new study found in a questionnaire that 51.4% of women preferred self-sampling for HPV-based cervical cancer screening.
Read More
Seegene’s New PCR Assay Offers Three-Target Cycle Threshold Value Tech
Molecular diagnostics company Seegene today announced the development of a commercialized PCR assay that applies “3 Ct” technology.
Read More
Same-Day Cervical Cancer Screening & Prevention Tool Streamlines Treatment
The cervical cancer screening tool enables physicians to detect and remove pre-cancerous cells from the cervix during the same appointment.
Read More
Why Cervical Cancer Screening Rates are Declining
Rates of cervical cancer screenings have dropped in the U.S., with rates lowest among Asian and Hispanic women.
Read More
Test Shows Benefit for Detecting Women at Risk for Cervical Cancer
Results from the IMPACT trial demonstrate clear patient benefit in using Roche’s CINtec PLUS Cytology dual-stain biomarker technology.
Read More
Some Women Receive HPV and Cervical Cancer Screening too often
Researchers have found that many women are screened for cervical cancer too often, while others are not getting tested often enough.
Read More
Circulating Tumor DNA Leads to Detection of HPV
Researchers have made new findings, which may improve detection of the human papillomavirus (HPV) in the bloodstream.
Read More
Novel Research Will Address Challenges in Women’s Health
Scientists have created a test to measure antibodies in girls who have received a vaccine for HPV, the leading cause of cervical cancer in women.
Read More
Cervical Cancer Screening Has Kept Rates Stable or in Decline
A recent trend analysis indicates that cervical cancer and mortality rates have remained stable or are dropping, in part, because of screening
Read More
ASCCP Discusses American Cancer Society Cervical Cancer Screening Guidelines
The ASCCP Cervical Cancer Screening Task Force has voiced its support for the ACS’s 2020 cervical cancer screening guidelines.
Read More
Women’s Health: Why Pap & HPV Cotesting Should Be Standard
With Pap tests and testing for HPV, cervical cancer rates have significantly declined. However, debate continues about cotesting.
Read More
Study Details Perceived Financial Barriers to Cervical Cancer Screening, Disparities in Care
The most commonly reported barriers were screening appointment costs (71%) and follow-up/future treatment costs (44%), according to the study.
Read More
Gold Leaf Could Help Diagnose Viral Infections in Low-Resource Settings
Researchers developed gold leaf electrodes that, in combination with a CRISPR-based assay, could sensitively detect HPV DNA in human samples.
Read More
Dual Biomarkers Improve Cervical Cancer Screening
How p16 and Ki-67 indicate transforming HPV infections.
Read More
Cervical Cancer Testing Tech Could Replace Pap Smears, Save Lives
Emerging techniques could help detect the virus leading to cervical cancer in low-income areas and developing nations.
Read More